pyrazolanthrone has been researched along with Koch's Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lau, AS; Li, JC; Ling, WL; Pong, JC; Wang, LJ | 1 |
Cho, JE; Cho, SN; Kim, YS; Lee, H; Park, S | 1 |
2 other study(ies) available for pyrazolanthrone and Koch's Disease
Article | Year |
---|---|
A role for interleukin-17A in modulating intracellular survival of Mycobacterium bovis bacillus Calmette-Guérin in murine macrophages.
Topics: Animals; Anthracenes; Bacterial Load; Cell Line; Cell Survival; Humans; Interleukin-17; Intracellular Space; Macrophages; MAP Kinase Kinase 4; MAP Kinase Signaling System; Mice; Mycobacterium bovis; Nitric Oxide; Nitric Oxide Synthase Type II; Phosphorylation; Tuberculosis | 2013 |
c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (p38 MAPK) are involved in Mycobacterium tuberculosis-induced expression of Leukotactin-1.
Topics: Anthracenes; Cell Line, Tumor; Chemokines, CC; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Mycobacterium tuberculosis; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyridines; Signal Transduction; Tuberculosis; Up-Regulation | 2012 |